These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24138426)

  • 61. Renin-Angiotensin-Aldosterone System and Migraine: A Systematic Review of Human Studies.
    Sassi KLM; Martins LB; de Miranda AS; Teixeira AL
    Protein Pept Lett; 2020; 27(6):512-519. PubMed ID: 31995000
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence.
    Kangussu LM; Marzano LAS; Souza CF; Dantas CC; Miranda AS; Simões E Silva AC
    Protein Pept Lett; 2020; 27(6):463-475. PubMed ID: 31849284
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinical significance of RAS block in heart diseases].
    Saito Y
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1750-5. PubMed ID: 17037310
    [No Abstract]   [Full Text] [Related]  

  • 64. Renin-angiotensin system intervention to prevent in-stent restenosis: an unclosed chapter.
    Langeveld B; Roks AJ; Tio RA; Voors AA; Zijlstra F; van Gilst WH
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):88-98. PubMed ID: 15613985
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Angiotensins in Alzheimer's disease - friend or foe?
    Kehoe PG; Miners S; Love S
    Trends Neurosci; 2009 Dec; 32(12):619-28. PubMed ID: 19796831
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence.
    Fouda AY; Artham S; El-Remessy AB; Fagan SC
    Clin Sci (Lond); 2016 Feb; 130(4):221-38. PubMed ID: 26769658
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of diabetes on abdominal aortic aneurysm growth over 2 years.
    Nordness MJ; Baxter BT; Matsumura J; Terrin M; Zhang K; Ye F; Webb NR; Dalman RL; Curci JA
    J Vasc Surg; 2022 Apr; 75(4):1211-1222.e1. PubMed ID: 34695550
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm.
    Iida Y; Sawa S; Shimizu H
    Curr Drug Targets; 2018; 19(11):1297-1301. PubMed ID: 29284387
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Angiotensin II receptor antagonists in acute coronary syndromes.
    Artom N; Montecucco F; Mach F; Dallegri F; Pende A
    Eur J Clin Invest; 2014 Feb; 44(2):219-30. PubMed ID: 24289238
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components.
    Kaschina E; Scholz H; Steckelings UM; Sommerfeld M; Kemnitz UR; Artuc M; Schmidt S; Unger T
    Atherosclerosis; 2009 Aug; 205(2):396-403. PubMed ID: 19193379
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Angiotensin II and Abdominal Aortic Aneurysms: An update.
    Liu J; Daugherty A; Lu H
    Curr Pharm Des; 2015; 21(28):4035-48. PubMed ID: 26306840
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Validation of Brain Angiotensin System Blockade as a Novel Drug Target in Pharmacological Treatment of Neuropsychiatric Disorders.
    Wincewicz D; Braszko JJ
    Pharmacopsychiatry; 2017 Nov; 50(6):233-247. PubMed ID: 28641333
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapeutic approach for neuronal disease by regulating renin-angiotensin system.
    Ohshima K; Mogi M; Horiuchi M
    Curr Hypertens Rev; 2013 May; 9(2):99-107. PubMed ID: 23971691
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does the angiotensin-converting enzyme (ACE) gene polymorphism affect rate of abdominal aortic aneurysm expansion?
    Yeung JM; Heeley M; Gray S; Lingam MK; Manning G; Nash JR; Donnelly R
    Eur J Vasc Endovasc Surg; 2002 Jul; 24(1):69-71. PubMed ID: 12127851
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transforming Growth Factor-β and the Renin-Angiotensin System in Syndromic Thoracic Aortic Aneurysms: Implications for Treatment.
    van Dorst DCH; de Wagenaar NP; van der Pluijm I; Roos-Hesselink JW; Essers J; Danser AHJ
    Cardiovasc Drugs Ther; 2021 Dec; 35(6):1233-1252. PubMed ID: 33283255
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacotherapy in Clinical Trials for Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis.
    Su Z; Guo J; Gu Y
    Clin Appl Thromb Hemost; 2022; 28():10760296221120423. PubMed ID: 36083182
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An update on the etiology of abdominal aortic aneurysms: implications for future diagnostic testing.
    Miner GH; Faries PL; Costa KD; Hanss BG; Marin ML
    Expert Rev Cardiovasc Ther; 2015 Oct; 13(10):1079-90. PubMed ID: 26401919
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pathophysiological Aspects of the Development of Abdominal Aortic Aneurysm with a Special Focus on Mitochondrial Dysfunction and Genetic Associations.
    Summerhill VI; Sukhorukov VN; Eid AH; Nedosugova LV; Sobenin IA; Orekhov AN
    Biomol Concepts; 2021 Jun; 12(1):55-67. PubMed ID: 34115932
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture.
    Fraga-Silva RA; Trachet B; Stergiopulos N
    Curr Pharm Des; 2015 Aug; ():. PubMed ID: 26306835
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current status of medical treatment for abdominal aortic aneurysm.
    Kurosawa K; Matsumura JS; Yamanouchi D
    Circ J; 2013; 77(12):2860-6. PubMed ID: 24161907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.